Autonomix Medical, Inc. cash flow statement AMIX

In fiscal 2026, which ended Mar 31, 2026, Autonomix Medical, Inc. used $12.3 million of cash from operations, down 48.7% from the year before. It spent $10,000 on capital expenditures. Free cash flow was negative, at -$12.3 million.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line
FY 2027
Jun 30, 2026
FY 2026
Mar 31, 2026
FY 2025
Mar 31, 2025
FY 2024
Mar 31, 2024
Operating
Depreciation and amortization
0
0
—
0
Stock-based compensation
0
1
—
1
Operating cash flow
-13
-12
-48.7%
-8
-25.1%
-7
Investing
Capital expenditures
—
0
—
0
Investing cash flow
—
-0
—
-0
Financing
Financing cash flow
8
10
—
14
Change in cash
Net change in cash
-5
-2
—
8
Free cash flow
—
-12
—
-7
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
AMIX (Nasdaq)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
The Woodlands, TX
SEC filer status
, Emerging growth company
SEC CIK
1617867

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.